About Neuphoria Therapeutics Inc
- Industry: Biotechnology
- Exchange: NASDAQ NMS - GLOBAL MARKET
- Country: US
- Website: https://www.neuphoriatx.com/
Frequently Asked Questions
What is the 52-week range for NEUP?
The 52-week high is $21.4004 and the 52-week low is $3.19.
What is the P/E ratio for NEUP?
The P/E ratio data is currently unavailable.
What is the dividend yield for NEUP?
This company does not currently pay a dividend or the data is unavailable.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is -55.91%.
What is the Net Profit Margin?
The Net Profit Margin (TTM) is -417.70%.
What is the Price to Book (P/B) Ratio?
The annual Price to Book ratio stands at 0.70.
Analyst Recommendation Trends
Wall Street analyst consensus for NEUP over the last few months:
Latest NEUP News
Scancell completes up to US$25 million in debt financing, providing optionality alongside equity investment to finance iSCIB1+ phase 3 development
OXFORD, United Kingdom and BURLINGTON, Mass., Sept. 24, 2026 (GLOBE NEWSWIRE) -- Scancell Holdings plc (AIM: SCLP) (“Scancell”, or the “Company”), a late-stage clinical immuno-oncology company developing active immunotherapies designed to enhance anti-tumor immune responses in difficult-to-treat cancers, announced today that, further to its announcement on 23 July 2026 regarding the planned merger with Neuphoria Therapeutics Inc. (“Neuphoria”) and financing to conduct the registrational Phase 3
Accenture, Abivax and 3 Stocks to Watch Heading Into Monday
Stocks in focus: Abivax, Marygold and Neuphoria report losses; Accenture partners with Anthropic, while Lobo Technologies posts H1 growth.
Neuphoria Therapeutics Q4 EPS $(0.95) Misses $(0.56) Estimate, Sales $1.174M.
Neuphoria Therapeutics (NASDAQ:NEUP) reported quarterly losses of $(0.95) per share which missed the analyst consensus estimate of $(0.56) by 69.64 percent. This is a 76.13 percent increase over losses of $(3.98) per
Related Stocks (Peers)
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2026-01-20 | Wilson David Ian | +8,537 | - | - |
| 2026-01-20 | Fisher Alan | +17,073 | - | - |
| 2026-01-20 | Davies Peter Miles Winston | +8,537 | - | - |
| 2026-01-20 | Ryan Jane | +8,537 | - | - |
| 2025-10-21 | Nichols Weston | +639,110 | $5.137 | $3,283,108 |